Medicinal Products

COVID-19 Vaccine Janssen

Name COVID-19 Vaccine Janssen
Active Substance Adenovirus tipa 26 koji kodira glikoprotein šiljka virusa SARS-CoV-2 (Ad26.COV2-S)
Prescription na recept
Type of prescription neponovljivi recept
Distribution u ljekarni
ATC Code J07BX03
Medicinal product marketed in the Croatia Da

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o kontraindikaciji primjene cjepiva COVID-19 Vaccine Janssen u osoba koje su prethodno imale sindrom kapilarnog curenja i nove informacije o sindromu tromboze praćene trombocitopenijom 19.07.2021 Janssen Cilag International N.V.
Pismo zdravstvenim radnicima o povezanosti primjene cjepiva COVID-19 Vaccine Janssen i pojave tromboze u kombinaciji s trombocitopenijom 26.04.2021 Janssen Cilag International N.V.
Back